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Abstract
Background: Pancreatic heterotopia (PH) is defined as ectopic pancreatic tissue outside the normal pancreas and
its vasculature and duct system. Most frequently, PH is detected incidentally by histopathological examination. The
aim of the present study was to analyze a large single-center series of duodenal PH with respect to the clinical
presentation.
Methods: A prospective pancreatic database was retrospectively analyzed for cases of PH of the duodenum. All
pancreatic and duodenal resections performed between January 2000 and October 2015 were included and
screened for histopathologically proven duodenal PH. PH was classified according to Heinrich’s classification (Type I
acini, ducts, and islet cells; Type II acini and ducts; Type III only ducts).
Results: A total of 1274 pancreatic and duodenal resections were performed within the study period, and 67 cases of
PH (5.3%) were identified. The respective patients were predominantly male (72%) and either underwent
pancreatoduodenectomy (n = 60); a limited pancreas resection with partial duodenal resection (n = 4); distal
pancreatectomy with partial duodenal resection (n = 1); total pancreatectomy (n = 1); or enucleation (n = 1). Whereas
65 patients (83.5%) were asymptomatic, 11 patients (18.4%) presented with symptoms related to PH (most frequently
with abdominal pain [72%] and duodenal obstruction [55%]). Of those, seven patients (63.6%) had chronic pancreatitis
in the heterotopic pancreas. The risk of malignant transformation into adenocarcinoma was 2.9%.
Conclusions: PH is found in approximately 5% of pancreatic or duodenal resections and is generally asymptomatic.
Chronic pancreatitis is not uncommon in heterotopic pancreatic tissue, and even there is a risk of malignant
transformation. PH should be considered for the differential diagnosis of duodenal lesions and surgery should be
considered, especially in symptomatic cases.
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Background
Pancreatic heterotopia (PH) was first reported by
Jean-Schultz in 1729 and is defined as pancreatic tis-
sue without anatomical or vascular connection to the
pancreas [1, 2].
The ectopic pancreatic tissue possesses its own duct
system and vascular supply [3, 4]. It is mostly found in
the upper gastrointestinal tract (GIT), but may occur
anywhere in the GIT [5, 6]. Frequent locations are the
duodenum (93.6%), stomach (24–38%), jejunum
(0.5–27%), and Meckel’s diverticulum (2–6.5%) [7].
The most widespread explanation of the origin of PH is
that the ectopic tissue separates itself from the pancreas
during embryonic rotation and fusion of the dorsal and
ventral pancreatic buds (misplacement theory) [3, 8]. For
a clinical understanding of PH it is important to know that
all diseases arising in the genuine pancreas can also de-
velop in heterotopic tissue [3, 6, 9, 10].
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Among all abdominal surgeries the incidence of PH
ranges from 0.25–1.2%, and specific symptoms have not
been described until now [11]. Most patients with PH
are asymptomatic, and PH is detected incidentally by
histological examination of the specimen. Although ma-
lignant transformation originating from PH is extremely
rare, it has been reported in several cases in the litera-
ture [12, 13]. Because of the scarcity of symptomatic PH
cases in the literature [6, 14–16], we investigated our
series of duodenal PH with a special focus on its clinical
relevance and impact.
Methods
We retrospectively analyzed our prospective pancreatic
database for cases with PH of the duodenum. All pan-
creatic and duodenal resections performed at the
Department of Visceral, Thoracic and Vascular Surgery,
University Hospital, TU Dresden between January 2000
and October 2015 were included. Partial results have
been published elsewhere [17]. Clinical symptoms, surgi-
cal procedures and pathological findings were docu-
mented for each case. At histological examination, the
specimens were stained with hematoxylin and eosin, and
a senior GI pathologist (DEA) reviewed each sample re-
garding the components of pancreatic tissue (including
acini, ducts, and islets of Langerhans). PH was classified
according to Heinrich’s classification (Fig. 1) [18]. Briefly,
PH Type I includes acini, ducts and endocrine islet cells,
Type II contains acini and ducts, but no islet cells, and
Type III contains only pancreatic ducts.
PH was classified as “symptomatic” if the surgery was
directly indicated for PH-associated pathologies, whereas
incidental PH diagnosed on postoperative histopatho-
logical examination was classified as “asymptomatic”.
We compared these two groups regarding type of PH,
associated disease and treatment.
In accordance with the guidelines for human subject
research, approval was obtained from the ethics commit-
tee at the Carl Gustav Carus University Hospital (deci-
sion number EK 435102015).
Results
Patient cohort
In total, 1274 pancreatic and duodenal resections were
performed in our department during the study period.
Some 67 cases (5.3%) with histologically proven duo-
denal PH were identified (19 women and 49 men). The
mean age of the whole cohort was 54 years (range 24–
76 years). The postoperative histology showed chronic
pancreatitis (CP) (n = 25; 37.3%), pancreatic ductal
adenocarcinomas (PDAC) (n = 11; 16.4%), and cystic
neoplasms (n = 11; 16.4%). Nine operated patients
(13.4%) had papillary carcinomas (AP) and six (9%) pre-
sented with neuroendocrine tumors (NET). More rare
Fig. 1 Heinrich’s classification of pancreatic heterotopia
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indications for operation included duodenal polyps (two
cases; 2.9%), one cholangiocarcinoma, one pancreas divi-
sum, and one duodenal carcinoma (Tables 1 and 2). Pan-
creatic head resections including pylorus-preserving
pancreatoduodenectomies (PPPD) and Whipple proce-
dures represented the vast majority of the operations
(n = 60; 89.5%). In four cases (5.9%) a segmental pancre-
atic resection with partial duodenal resection was per-
formed. Furthermore, one patient each underwent a
distal pancreatectomy with partial duodenal resection, a
total pancreatectomy and an enucleation of the pancreas
and the duodenum (1.4%). According to Heinrich’s clas-
sification, Type I PH was found in 32 patients (47.9%),
Type II in 28 patients (41.7%), and Type III in 7 patients
(10.4%) (Tables 1 and 2).
“Asymptomatic” subgroup
Fifty-six of the 67 patients (83.5%) were classified as
asymptomatic. Performed operations, and postopera-
tive histology are shown on Table 1. In this subgroup
the following types of heterotopia were diagnosed:
Type I, n = 26; Type II, n = 24; and Type III, n = 6.
The patients in the “asymptomatic” cohort presented
with the following complaints of the underlying non-
PH associated disease (e.g., pancreatic malignancy or
chronic pancreatitis): obstructive jaundice, upper ab-
dominal pain, vomiting/nausea, weight loss or duo-
denal obstruction (Table 1).
“Symptomatic” subgroup
In 11 cases (16.4%) duodenal PH was responsible for the
clinical symptoms (symptomatic subgroup) (Table 2). In
this subgroup Heinrich’s Type I and II were predomin-
antly found (Type I n = 6; Type II n = 4 and Type III
n = 1). Interestingly, the most frequent PH-related
symptom was upper abdominal pain (n = 8, 72%), and
duodenal obstruction (n = 6, 55%). The postoperative
histological examination of the symptomatic patients re-
vealed chronic pancreatitis in 7 patients (64%), PDAC in
two patients (18%), and duodenal tumors in two cases
(18%) originating from the existing duodenal PH. There
was no difference in age, sex and type of surgery be-
tween the two groups, and there was no significant dif-
ference regarding related disease or Heinrich type
(p > 0.05) between the symptomatic and asymptomatic
cases (Table 3).
Discussion
PH is described as a rare pathological entity, and a pre-
operative clinical diagnosis is difficult because character-
istic clinical symptoms are frequently camouflaged by
the multitude of underlying diseases [3, 6, 19]. Clinical
series are rare and most data in the literature stem from
case reports.
The present study focused on duodenal PH. Ap-
proximately 5% of the patients undergoing pancreatic
and/or duodenal resections in our cohort were diag-
nosed with PH, and thus PH was not a particularly
Table 1 Characteristics of “asymptomatic patients” with duodenal PH (n = 56) (Indication for operation due to clinical presentation
and symptoms)
Type of duodenal PH
(according to Heinrich)
Age (mean)
Sex (m/f)
Operation Clinical presentation and symptomsa Histology
Type 1 n = 26 57.4 years
(16/10)
1xpancreatectomie;
3xWhipple;
19× PPPD;
2× partial duodenal resection;
1× enucleation of the pancreas and the
duodenum
11xobstructive jaundice
9xepigastric pain
6xrecurrent pancreatitis
duodenal stenosis
5xloss of weight
recurrent hypoglycemia
acid reflux
SCN
5xPDAC
5xIPMN
6xCP
5xAP
4xNET
Type 2 n = 24 55.9 years
(18/6)
19xPPPD
4xWhipple
Pancreas left resection
9xrecurrent pancreatitis
7xobstructive jaundice
10xepigastric pain
diarrhoe
3xdilatation pancreas duct
2xpseudocyst
2xduodenal stenosis
5xweight loss
gastric stenosis
2xcholestasis
4xIPMN
Carcinoma of the bile
duct
3xAP
9xCP
2xNET
4xPDAC
SCN
Type 3 n = 6 57.2 years
(4/2)
5xPPPD
1xWhipple
2xrecurrent pancreatitis; 3xobstructive
jaundice; 3xepigastric pain; 1xpseudocyst;
1xcystic tumor; 1xampullary tumor;
1xduodenal stenosis; 1× dilatation
pancreatic duct
1xPDAC;
3xCP; 1xAP;
1xpancreas divisum
amultiple answers possible;
PDAC pancreatic ductal adenocarcinoma, CPchronic pancreatitis, APampullary carcinoma, SCN serous cystic neoplasia, IPMN intraductal papillary mucinous
neoplasia, NET Neuroendocrine tumor
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rare finding. Our study confirms that most of the pa-
tients with PH were asymptomatic, and therefore PH
was discovered incidentally. However, depending on
its location and diameter, heterotopic pancreatic tissue
can lead to nonspecific symptoms [20–22]. According
to the literature, lesions are more likely to be symp-
tomatic if they are >2 cm in diameter [23]. This
seems to be especially true for tumors that are lo-
cated in the duodenum due to the anatomic character
of this region of the digestive tract. Nevertheless, due
to a lack of data concerning the diameter of the duo-
denal PH-lesions we could not make a clear state-
ment to this point. But abdominal pain is the most
common –but nonspecific– symptom of pancreatic
heterotopia, [4] as found in the present study (73%).
Consequently, the nonspecific set of symptoms makes
the clinical diagnosis of PH challenging; none of the
patients in the present analysis was diagnosed with
PH preoperatively.
Differential diagnosis of duodenal heterotopia
In general, PH lesions in the GIT are detectable by en-
doscopy. PH often presents as a submucosal swelling
covered by normal mucosa and can easily be mistaken
as gastrointestinal stroma tumor (GIST) or leiomyoma
using endoscopy, ultrasonography or CT scanning [24].
In addition the risk of false negative biopsy results is
high because ectopic tissue is most commonly located in
the submucosal layer (76%), and sporadically appears in
the muscular layer (15%), or in the subserosa (9%) [25].
Therefore, most biopsies are inconclusive, because of in-
adequate tissue samples [22]. In this context, endoscopic
ultrasound-guided fine-needle aspiration (EUS-FNA) has
been found to be valuable in the diagnosis of upper GIT
lesions [26, 27].
In the present study, endoscopic ultrasound was not
one of the standard preoperative investigations but
the lesions were differentiated by preoperative CT
and/or MRI scans (Fig. 2). If one looks on the pre-
sented CT-scan of a duodenal PH, it was especially
difficult to distinguish the tumor from the original
pancreas because of the close proximity of the two
organs (Fig. 2). Based on current data on the value of
EUS in the diagnosis of upper GIT lesions, EUS
should be performed if a submucosal lesion is sus-
pected. From the clinical point of view it is often im-
possible to distinguish GIST, lymphomas, peptic ulcer
disease, or malignancies from heterotopic pancreatic
tissue [16, 20, 22]. To diagnose PH, histopathological
examination is therefore essential.
Table 2 Characteristics of “symptomatic patients” with lesions originating from duodenal PH or symptoms due to duodenal PH
(n = 11)
Type of duodenal PH
(according to Heinrich)
Age (mean)
Sex (m/f)
Operation Clinical presentation and symptomsa Histology
Type 1 n = 6 58.6 years
(5/1)
3xWhipple; 3xPPPD 3xduodenal stenosis; 4xepigastric pain;
1xnausea/vomiting; 1xobstructive jaundice;
1xweigth loss; 1xpseudocysts
3xCP in PH; 2xPDAC in PH;
1× PH in duodenal wall
Type 2 n = 4 47.8 years
(4/0)
2xpartial duodenal
resection;
1xWhipple; 1xPPPD
3xduodenal stenosis; 3xepigastric pain;
1xNausea/vomiting;
1xobstructive jaundice; 1xpseudocysts
1× PH in duodenal wall;
3xCP in PH
Type 3 n = 1 47.0 years male PPPD recurrent epigastric pain CP in PH
amultiple answers possible
PDAC pancreatic ductal adenocarcinoma, CP chronic pancreatitis, PH pancreatic heterotopia
Table 3 Comparison of the asymptomatic and symptomatic
subgroups
Asymptomatic
Subgroup n = 56
Symptomatic
Subgroup n = 11
p-value
Mean age y (±SD) 56,7 (12.5) 53,6 (12.3) p = 0.45
Sex (m/f) 38/18 10/1 p = 0.12
(X2 = 2.405)
Type of surgery
(n=)
PPPD n = 43 n = 5 p = 0.10
(X2 = 4.515)
Whipple n = 8 n = 4
Other n = 5 n = 2
Associated disease
(n=)
PDAC n = 10 n = 2 p = 0.05
(X2 = 10.47)
CP n = 18 n = 7
Cystic neoplasia n = 11 n = 0
NET n = 6 n = 0
AP n = 9 n = 0
Other n = 2 n = 2
Heinrich Type
I 26 6 p = 0.88
(X2 = 0.2428)
II 24 4
III 6 1
PDAC pancreatic ductal adenocarcinoma, CP chronic pancreatitis, NET
neuroendocrine tumor
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Malignant transformation of pancreatic heterotopia
Several studies have demonstrated that any disease of
the ordinary pancreas can also arise in the heterotopic
tissue, such as acute and chronic pancreatitis, the occur-
rence of pseudocystic changes, or even a malignant
transformation to adenocarcinoma or acinar cell carcin-
oma [3, 6, 10, 16, 28–30]. The present results are in line
with these findings, as two out of 67 patients with PH
developed adenocarcinoma by malignant transformation
of the heterotopic pancreatic tissue (2.9%). Guillou et al.
stated that the incidence of malignancy due to hetero-
topic pancreatic tissue is 0.7% and therefore is extremely
rare [13]. They studied the frequency of malignant trans-
formations among 146 cases of PH between 1975 and
1991, including surgical and autopsy specimens. In a
study by Makhlouf et al. two out of 109 patients (1.8%)
with PH of the gastrointestinal tract were diagnosed with
adenocarcinoma between 1970 and 1997 [12]. Malig-
nancy is therefore a differential diagnosis and should be
excluded. Furthermore, histopathological examination of
the resected specimen of the 11 symptomatic patients in
the present study showed chronic pancreatitis in seven
cases (63.6%) and a duodenal tumor (adenoma) with no
signs of chronic pancreatitis or malignancy in two cases
(18%). Interestingly cystic lesions or NET arising from a
duodenal PH were not found in our symptomatic sub-
group. Furthermore, no specific Heinrich’s type was as-
sociated with symptoms or malignancy.
Management of PH
For patients with symptomatic PH, local resection of the
lesion seems to be the most appropriate therapy [16].
Patients underwent partial duodenal resections in two
cases due to a symptomatic PH with suspicion of a duo-
denal tumor after intraoperative exclusion of malignancy
by frozen section. Although endoscopic therapy is cur-
rently being evaluated for removal of ectopic pancreatic
tissue, surgery remains the standard therapy [31, 32]. If
histologically proven PH is asymptomatic and malig-
nancy is definitely excluded, it can be treated conserva-
tively. Nevertheless, if PH is found incidentally during a
surgical procedure, excision should be considered due to
its potential for becoming symptomatic and malig-
nant. If malignancy is suspected extended oncological
surgical resection (e.g., PPPD) is justified. The prog-
nosis of patients with adenocarcinoma arising from
PH seems to be better compared to patients with tu-
mors arising from the pancreas itself, probably due to
earlier presentation [16, 33].
Conclusion
In summary, PH of the duodenum represents a rare
diagnosis and most patients are asymptomatic. Duodenal
PH is mostly diagnosed by histological evaluation of sur-
gical specimens resected for different pathologies.
Nevertheless, the present results indicate that nearly all
diseases of the genuine pancreas can occur in hetero-
topic pancreatic tissue. Therefore, depending on the
current disease, different symptoms can appear and lead
to another diagnosis. Ectopic duodenal pancreatic tissue
should be considered in the differential diagnosis when a
duodenal lesion is detected. Surgical resection is indi-
cated if the lesion is symptomatic or malignancy cannot
be excluded.
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